A new assay for chloramphenicol in biological fluids has been developed that offers sensitivity, specificity, precision, accuracy, economy, and ease of performance. The assay is based on the enzymological acetylation of chloramphenicol catalyzed by an R factor-mediated enzyme. ['4C]acetyl coenzyme A serves as the donor of the labeled acetyl group, and the product, ["4C]acetoxychloramphenicol, is separated from the labeled precursor by utilizing its preferential extraction into benzene. The product is then quantified by liquid scintillation counting. This assay measures chloramphenicol concentrations in both plasma and other biological specimens and in the presence of other antibiotics, hemolysis, or jaundice. Its rapidity and ease ofperformance are useful for clinical laboratories, and its sensitivity allows determinations on 10 ,ul of plasma.
Plasma chloramphenicol levels are clinically useful in helping to skirt between ineffectiveness and toxicity in patients who respond in a heterogeneous manner to the drug.
Several methods for the quantification of chloramphenicol in biological fluids have been devised (1-7, 10, 11, 15) , but to date none has been entirely satisfactory. We have developed an enzymological assay for chloramphenicol in biological fluids that offers sensitivity, specificity, precision, accuracy, economy, and ease of performance. This method is based on the specific acetylation of chloramphenicol with a radioactively labeled acetyl group derived from ['4C]acetyl coenzyme A and catalyzed by an R factor-mediated acetyltransferase. Both the reaction and the enzyme have been previously characterized (12) (13) (14) . This report describes the adaptation of this reaction to a clinically useful assay.
(This paper was presented in part at the 73rd Annual Meeting of the American Society for Microbiology, 6-11 May 1973, Miami Beach, Fla.).
MATERIALS AND METHODS
Enzyme preparations. Chloramphenicol acetyltransferase was used as both a highly purified preparation (253 U/mg of protein) and a crude "osmotic shock fluid" (about 10 U/mg of protein). The former was purified as described previously (13) employing affinity chromatography (Y. Zaidenzaig and W. V. Shaw, FEBS Lett., in press). The crude osmotic shock fluid was prepared as follows. A strain ofEscherichia coli (JR66/W677), harboring an R factor for chloramphenicol resistance, was subjected to osmotic shock by the method of Nossal and Heppel (8) . This method was originally used because we had previously prepared an adenylylating enzyme for the measurement of gentamicin levels from the same strain of E. coli. The use of the shocking procedure is not meant to localize the intracellular distribution of the enzyme since we have no evidence that many intracellular enzymes as well as periplasmic enzymes were not released as we shocked the cells. the osmotic shock fluid was brought to a final concentration of 10 mM tris(hydroxymethyl)aminomethane (Tris)-hydrochloride (pH 7.8 at 5°C), 10 mM mercaptoethanol, and 5.0 mM magnesium chloride and was purified one step further by ammonium sulfate fractionation. The activity of the enzyme preparations was measured in the assay system described below but with 347 an excess of chloramphenicol (0.12 mM) and with the enzyme diluted so that the incorporation of labeled acetate was linear with respect to both time and enzyme concentration. One unit of enzyme activity was taken to be the amount sufficient to monoacetylate 1 ,umol of chloramphenicol per min under the conditions specified.
Quantification of chloramphenicol by gas-liquid chromatography. The method of Resnick et al. (10) 
RESULTS
Assay. The acetylation reaction is carried out in a final volume of 260 ,ul in 15-ml conical centrifuge tubes. The reaction contains, as final concentrations, 0.1 M Tris-hydrochloride (pH 7.8 at 37°C) and 0.2 mM l'4C]acetylcoenzyme A (1.5 mCi/mmol). Enzyme (0.5 x 10-3 to 1.25 x 10-3 U of activity corresponding to about 50 ng of protein) is added by adding 25 ,Iu of a 1:100 dilution of a crude, dialyzed shock fluid prepared as above. Water is added to bring the volume of the mix to 250 ml. In practice, an assay mix of the above components is prepared for the appropriate number of samples to be analyzed, and 250 al of this mix is added to each tube.
The reaction is initiated by the addition of 10 ANTIMICROB. AGENTS CHEMOTHER.
M1 of plasma or water containing the chloramphenicol and is continued at 37°C for 30 min. At the conclusion of the incubation period, the reaction mixture is extracted with three 1.0-ml portions of benzene by agitation on a Vortex mixer. Chloramphenicol, chloramphenicol monoacetate, and chloramphenicol diacetate are extracted quantitatively into benzene at an alkaline pH (pH > 7.5), while the acetate anion and acetyl coenzyme A remain in the aqueous phase. The tubes are centrifuged briefly after each addition of benzene (1 min at 1,000 x g), and the supernatant fluids are decanted with Pasteur pipettes into scintillation vials. Alternatively, the aqueous layer may be quickly frozen by dipping the lower portion of the tubes into an acetone-dry ice bath and the benzene layer, which remains unfrozen, may be poured directly into the scintillation vials. A 5-ml amount of a toluene-based scintillation fluid (toluene, 700 ml: ethanol, 300 ml; 2,5-diphenyloxazole, 3 g', p-bis-2-(5-phenyloxazolyl)benzene, 100 mg) is added to the pooled benzene phases, and the samples are counted at an efficiency of about 75% (as measured by the channels ratio method) in a Nuclear-Chicago model 6225 liquid scintillation counter.
The sensitivity of the assay can be improved by drying the benzene solution with mild heating under a stream of nitrogen of air. We have found this useful when measuring concentrations of less than 5 ,ug/ml.
Acetate incorporated into acetylated chloramphenicol was measured as counts per minute over control counts realized with reaction mixtures containing no antibiotic. These control counts, seen with control reaction mixtures containing 10 ul of plasma but lacking chloramphenicol, ranged from 30 to 50 cpm as compared with about 900 cpm above background for 10 ,.g of chloramphanicol per ml. This is no higher than the background on our instrument and indicates that there is no interference from benzene-extractable substrates present in plasma that might be nonspecifically acetylated.
The assay, as described above, utilizes only one part of the overall reaction, which proceeds through monoacetylation to diacetylation ofthe chloramphenicol. We can, by adjusting the amount of the enzyme in the reaction mixture, effect either a diacetylation or a monoacetylation of chloramphenicol. An example of a time course that was realized when 0.6 U of enzyme activity (600 times the usual amount) was provided to the system is shown in Fig. 1 . An initial rapid reaction (monoacetylation) is followed by a slower second phase (diacetylation). By increasing the amount of enzyme still fur- We have, therefore, taken advantage of the finding that the rate of addition of the second acetyl group, under our conditions, is much slower than the rate of addition of the initial acetyl group (13) . The time course of a typical monoacetylation reaction, utilizing 0.001 U of enzyme, is illustrated in Fig. 2 . The slowness of the subsequent addition of a second acetyl group at this concentration of enzyme provides ample leeway for stopping the reaction. Thus, we have selected 30 min as our usual time for cessation of the reaction. Continuing the assay an additional 30 min would add only 4% to the result.
Stability of the enzyme. The activity of the dialyzed crude enzyme preparation was monitored in the frozen, frozen-thawed, and dilute frozen-thawed states. Preliminary results suggest that roughly half of the acetylating activity is lost in the first month of storage at -20°C, but the enzyme remains reasonably stable thereafter. Greater than 90% of the original activity of purified enzyme can be realized after 1 year if the enzyme is kept at -40°C in 50 mM Tris (pH 7.8), 0.1 mM mercaptoethanol, 0.2 M NaCl, and 0.1 mM chloramphenicol. Since such small amounts of enzyme are required in the assay and a typical preparation yields enough enzyme for about 8,000 assays, the 1 day required to prepare the dialyzed shock fluid should present no great inconvenience, even if it is necessary to repeat this preparation every 3 to 4 months.
Products. The products of the acetylation reaction that are extractable into benzene were verified by thin-layer chromatography using silica gel plates (Analtech) and a chloroformmethanol (90:10) solvent system (12) . Labeled products were visualized by autoradiography and quantified by strip counting. Chloramphenicol-3-acetate (Rf = 0.60) is the main product of the monoacetylation assay along with very small amounts of chloramphenicol-1-acetate (R, = 0.46) and chloramphenicol-1,3-diacetate (Hf = 0.83). Under conditions described above for diacetylation, there was a disappearance ofthe peaks atR, = 0.60 andR, = 0.46 and an accumulation of label at Rf = 0.83.
The benzene-extractable products of the monoacetylation and diacetylation systems were also subjected to analysis by gas-liquid chromatography. The benzene solution was evaporated as described, 100 Al of Tri-Sil (Applied Science) was added to form silylated derivates, and 0.5-,ul samples were injected into the gas chromatograph. In the monoacetylation reaction, the peak corresponding to chloramphenicol disappeared with the subsequent appearance of a new peak of similar area at a longer retention time.
Standard curve. The dependence of the formation of product on chloramphenicol concentration was shown by standard curves made by assaying known amounts of chloramphenicol in water or acid-citrate-dextrose plasma. Conditions were selected such that the response was linear with chloramphenicol concentration from 1 to 50 ,ug/ml, using 10 1lI of sample as shown in Fig. 3 conditions in which these drugs are known to be bound.
The results of the assay as applied to chloramphenicol sodium succinate, chloramphenicol glucuronide, and L-threo chlorampehnicol are shown in Table 2 . Neither 1-threo chloramphenicol nor the sodium succinate ester of chloramphenicol was measured in the assay. Chloramphenicol glucuronide was also not detected. This conclusion is based on the fact that the enzymatic and gas-liquid chromatographic analyses of urine from a patient receiving chloramphenicol contained equal amounts of chloramphenicol; chloramphenicol glucuronide is known not to be measured by the chromatographic method. The addition of a known amount of chloramphenicol to the urine is accurately measured. The hydrolysis of chloramphenicol glucuronide by beta-glucuronidase yielded similar quantities when measured by Accuracy. The accuracy of the assay was assessed by adding a known amount of chloramphenicol to plasma already containing a measured level of chloramphenicol and repeating the assay. In a series of such "spiking" experiments on 10 different patient samples, the addition of 10 ,ug/ml was measured as an average of 11.5 ,ug/ml. We have not yet found the cause of the slightly higher values usually measured.
Reproducibility. The reproducibility of the assay was assessed by repeating the assay in duplicate 10 times on a single sample. The mean and standard deviation were 19.0 0.8 ,ug/ml for one set of 10 samples. The same sample was also reassayed 10 times over a period of several weeks. The mean and standard deviation were 18.5 0.8 jig/ml. All values presented in this paper are the averages of duplicate determinations.
Variation in standard curves. For a clinical assay, in which a large number of samples may need to be measured, it is of value to ascertain the necessity for generating a standard curve for each batch of samples. Eleven standard curves obtained over a 1-month period were compared and a mean standard curve was computed. The average deviation of points from the mean was ±7%. Therefore, once a standard curve has been established for a particular lot of radioactive acetyl coenzyme A, it should be sufficient to determine a background value and one standard concentration for comparison with the average standard curve.
Effects of hemolysis and jaundice. The accuracy of the assay was tested in the presence of plasma from hemolyzed blood and in jaundiced plasma obtained at an exchange transfusion. A 100-,ug/ml standard of chloramphenicol in normal plasma was diluted to 20 ug/ml with normal, hemolyzed, or jaundiced plasma and the drug concentration was measured. Neither hemolyzed nor jaundiced plasma affected the determination of the chloramphenicol concentration since the chloramphenicol concentrations (in micrograms per milliliter) were as follows: normal plasma sample, 20; hemolyzed plasma, 20; and jaundiced plasma, 20.5.
Binding of chloramphenicol to serum proteins and erythrocytes. An assessment was made to determine whether the assay measures the free or total (free plus protein bound) chloramphenicol in plasma. Preliminary evidence, from the similarity of the extent of [14C]acetate incorporation into chloramphenicol when standards were prepared in water and in plasma and from the similarity of values obtained by the enzymatic and gas-liquid chromatographic methods, indicated that the acetylation assay measures both free and bound drug. An equilibrium dialysis experiment was performed by suspending a dialysis bag containing 2 ml of plasma in 50 ml of a 0.1 M Tris buffer solution (pH 7.8) containing 20 gg of chloramphenicol per ml. The final concentrations of chloramphenicol inside and outside the dialysis bag were measured at equilibrium. If the assay measures only the free chloramphenicol, the concentration determined inside and outside the dialysis bag should have been equal. Since a higher level was measured inside the bag than in the dialysis solution (Table   3) , the assay appears to measure both free and bound drug.
The effect of chloramphenicol binding to erythrocytes and its possible release upon hemolysis were also studied. Portions of a 100-,ug standard of chloramphenicol per ml in plasma were diluted 1:5 with normal plasma and with whole blood. One of the blood samples was then incubated at 4°C for several hours to allow the chloramphenicol present to bind to the erythrocytes. Another blood sample containing chloramphenicol was hemolyzed by freezing and thawing, and then both samples were centri- Table 3 . Binding of chloramphenicol to erythrocytes with 'subsequent centrifugation or hemolysis does not affect the concentration of chloramphenicol measured in the supernatant.
Assay of chloramphenicol in biological fluids other than plasma. Chloramphenicol has been assayed by our method in plasma, serum, blood, cerebrospinal fluid, urine, peritoneal fluid after peritoneal dialysis, ascitic fluid, and synovial fluid. "Spiking" experiments on each of the fluids have failed to detect the presence ofany inhibitory substances in these fluids that might interfere with the assay, and control experiments on plasma and urine in the absence of chloramphenicol suggest there are no natural substrates present that are acetylated and then extracted into benzene. Thus, the assay can be carried out on biological specimens from many sources. DISCUSSION Several methods have been described previously for the assay of chloramphenicol in biological fluids. Each of these has some advantages and each has limitations.
Perhaps, the most commonly used method continues to be the bioassay (3) . Although the bioassay has the advantage of ease of performance, its sensitivity is limited, its precision appears to be variable, it requires at least several hours to complete, the specificity is poor in samples containing other antimicrobial agents, and specimens must be handled aspetically.
In an effort to improve on the bioassay, several colorimetric assays have been developed ANTIMICROB. AGENTS CHEMOTHER.
(1, 2, 4, 5, 9). Each of these measures the amine formed after reduction of the aromatic nitro group of chloramphenicol. Since chloramphenicol sodium succinate and chloramphenicol glucuronide both contain the nitro group, both are also measured and solvent extractions must be included to separate these from the chloramphenicol prior to the assay. Furthermore, none is designed to be done on a microscale, and all require at least 0.5 ml of blood for duplicate determinations.
Much greater sensitivity and specificity are provided by several gas-liquid chromatographic procedures utilizing either flame ionization (6, 7, 11) or electron capture (10, 15) detectors. These methods are time consuming, however, since a standard curve must be generated each day and a column must be dedicated to this assay.
The assay that we have developed overcomes each of the disadvantages of previous assays. Specificity is provided by the specificity of the enzyme that acetylates chloramphenicol but fails to acetylate any other known antibiotic (with the exception of the related thiamphenicol) or endogenous compound. Thus, chloramphenicol can be measured in the presence of other chemotherapeutic agents and other drugs without interference. We also have yet to find, in many hundreds of clinical assays, a plasma containing an inhibitor of the enzymatic reaction. Although this remains a theoretical possibility, it has not been realized to date. An appropriate degree of sensitivity is provided by the chosen specific activity of the [14C]acetyl coenzyme A. Although greater sensitivity than we have used is possible with the use of acetyl coenzyme A of even high specific activity, our method allows the accurate determination of therapeutic concentrations of chloramphenicol with only 10 ,ul of plasma. Thus, our assay can be easily performed on the plasma recovered from two microhematocrit tubes. Counts that are double background are seen at levels of chloramphenicol of about 0.25 ,tg/ml, using 10 ,ul of plasma. The accuracy of our method, when compared with a gas chromatographic method or when considered in absolute terms, is excellent and the precision achieved is certainly comparable to or better than any other existing method. The time involved in the performance of the assay is small (about 2 h, including a standard curve) and the cost of the assay is low. The cost of our assay, excluding technician time, is estimated to be about 27c per tube. The disadvantages of our assay are minor. An enzyme must be prepared since, at the present time, the enzyme is not commeron June 16, 2017 by guest http://aac.asm.org/ Downloaded from cially available. This preparation takes little time, however, and the small amount used per assay coupled with the stability of the frozen enzyme allows one to perform about 1,000 assays from a single preparation that began with 900 ml of culture. Another potential disadvantage is the necessity for a liquid scintillation counter. Such instruments are, however, widely available and present in clinical laboratories in increasing numbers. The advantages of this new assay clearly outweigh the disadvantages, and we believe that it can be of great value in therapeutic monitoring.
